The corporate-backed artificial intelligence technology producer is looking to raise $500m to $1bn as an alternative to going public.

Edge computing network provider has pushed its total funding to $396m in a series B round co-led by Juniper Networks and Cox Communications.

The antibody therapy developer closed a $100m round co-led by Lilly Asia Ventures that will fund phase 3 clinical studies for its lead drug candidates.

WeWork-backed Proxy has raised series B funding that will help it expand its online-to-offline identity verification system across multiple continents.

Telstra Ventures led cloud container technology developer Rancher's series D round, which increased its overall funding to $95m.

Axel Johnson investment fund Novax co-led a $15.3m round for the vegan protein and dairy substitute developer with Capricorn Partners Sustainable Chemistry Fund.

The Lloyds Banking subsidiary has backed e-commerce fulfilment platform developer James and James, providing $15.5m in funding.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Unnamed investors have added $1.2bn to a round already featuring AIA, Mitsubishi, Visa, SCB, Astra International, Tencent, JD.com and Google that reportedly now totals near $3bn.

The pharmaceutical firm was among the investors in a series G round that valued precision medicine technology provider Tempus at $5bn.